Fundraising Fox

Ben Freeberg

Investor

Founder, Managing Partner at Oncology Ventures

Austin, Texas, United States

About

Founder of Oncology Ventures. A testicular cancer survivor diagnosed in 2018, his firsthand experience with the fragmented cancer care system motivated him to start the firm to back founders building the future of cancer care.

Experience

  1. Oncology VenturesFounder, Managing Partnercurrent2022 — presentAustin, Texas
  2. Alpha PartnersVenture Partnercurrent2022 — present
  3. Thyme CareAdvisor2022 — 2023
  4. Thyme CareDirector of Growth2021 — 2022
  5. Optum VenturesVice President2019 — 2021Greater Boston Area
  6. Alpha PartnersSenior Associate2016 — 2019New York City
  7. Peter J. Solomon CompanyInvestment Banking Analyst2015 — 2016New York City
  8. Susquehanna Growth Equity (SGE)Private Equity Analyst2014Bala Cynwyd, PA
  9. Council for Entrepreneurial DevelopmentMarketing and Consulting Intern2012Durham, NC

Education

  1. Duke UniversityB.Sc. in Economics, Finance minor; Markets and Management Certificate

Skills & more

Data Analysis16Marketing7Financial Modeling16Statistics3Financial Analysis4Economics2Python8Microsoft Excel12HTML2WordPress2

From Ben's professional profile.

Same school

Shared employers

Deals · 28

Health UniverseSolo GP

via Oncology Ventures

IgniteSolo GP

via Oncology Ventures

IgniteDataSolo GP

via Oncology Ventures

KadanceSolo GP

via Oncology Ventures

LumonousSolo GP

via Oncology Ventures

LumonusSolo GP

via Oncology Ventures

mPATHSolo GP

via Oncology Ventures

mPATH HealthSolo GP

via Oncology Ventures

NexcureSolo GP

via Oncology Ventures

OncoveryCareSolo GP

via Oncology Ventures

Precision medicineSolo GP

via Oncology Ventures

Reimagine CareSolo GP

via Oncology Ventures

RISASolo GP

via Oncology Ventures

Risa LabsSolo GP

via Oncology Ventures

SpotdocSolo GP

via Oncology Ventures

Stitch HealthSolo GP

via Oncology Ventures

TonoSolo GP

via Oncology Ventures

ToñoSolo GP

via Oncology Ventures

TonohealthSolo GP

via Oncology Ventures

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Colleagues at Oncology Ventures